0.33
-0.0129(-3.76%)
Currency In USD
Address
301 Binney Street
Cambridge, MA 02142
United States of America
Phone
617 655 7500
Website
Sector
Healthcare
Industry
Biotechnology
Employees
115
First IPO Date
June 12, 2020
| Name | Title | Pay | Year Born |
| Dr. Cameron Geoffrey McDonough M.D. | President, Chief Executive Officer & Director | 1.02M | 1970 |
| Ms. Yalonda Howze J.D. | Chief Legal Officer & Secretary | 568,809 | 1972 |
| Dr. Phillip Samayoa Ph.D. | Chief Scientific Officer | 680,956 | 1987 |
| Ms. Antoinette Paone M.B.A., M.S. | Chief Operating Officer | 681,155 | 1978 |
| Dr. Robert Kotin Ph.D. | Co-Founder | 0 | 1956 |
| Caitlin Cooper M.B.A. | Senior Vice President & Head of Business Development | 0 | N/A |
| Mr. Kevin John Conway | Chief Financial Officer | 0 | N/A |
| Dr. Mark D. Angelino Ph.D. | Co-Founder | 0 | 1973 |
| Ms. Jasmin Tower | Chief Human Resources Officer | 0 | N/A |
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.